GlassScriptPhysician profile
Jose Soto
NPI 1063707578
$1,996.94
in general payments reported to CMS, 2019-2025
10 companies · $33.93 in 2025
The $33.93 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $191 · 2021: $158 · 2022: $923 · 2023: $138 · 2024: $61.09 · 2025: $33.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $793.45 | 2022 | |
| Biom'Up France Sas | $291.65 | 2020-2021 | |
| Biom'Up Sa | $171.88 | 2019 | |
| Integra Lifesciences Corporation | $156.08 | 2023-2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Boston Scientific Corporation | $138.36 | 2019-2020 | |
| Veloxis Pharmaceuticals, INC. | $129.87 | 2022 | |
| Eisai INC. | $125.00 | 2019 | |
| Kci USA, INC. | $76.80 | 2023 | Prevena, V.A.C. Veraflo |
| Medline Industries LP | $57.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.31 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.